M4141
Acide méthanesulfonique solution
4 M (with 0.2% (w/v) tryptamine)
Synonyme(s) :
Sulfomethane
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
Formule linéaire :
CH3SO3H
Numéro CAS:
Poids moléculaire :
96.11
UNSPSC Code:
12352209
NACRES:
NA.21
PubChem Substance ID:
EC Number:
200-898-6
Beilstein/REAXYS Number:
1446024
MDL number:
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderform
liquid
Quality Level
concentration
4 M (with 0.2% (w/v) tryptamine)
storage temp.
2-8°C
SMILES string
CS(O)(=O)=O
InChI
1S/CH4O3S/c1-5(2,3)4/h1H3,(H,2,3,4)
InChI key
AFVFQIVMOAPDHO-UHFFFAOYSA-N
Application
For complete protein and peptide hydrolysis with tryptophan recovery. After hydrolysis the samples are diluted prior to amino acid analysis.
Packaging
Ampules sealed under argon.
Disclaimer
air sensitive, store under inert conditions
Still not finding the right product?
Explore all of our products under Acide méthanesulfonique solution
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B - Skin Sens. 1 - STOT SE 3
target_organs
Respiratory system
Classe de stockage
8A - Combustible corrosive hazardous materials
wgk
WGK 2
ppe
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Gulfam Ahmad et al.
Frontiers in pharmacology, 11, 556020-556020 (2020-10-13)
Chronic inflammatory bowel disease (IBD) is a condition with multifactorial pathophysiology. To date, there is no permanent cure and the disease is primarily managed by immunosuppressive drugs; long-term use promotes serious side effects including increased risk malignancies. The current study
Luke F Gamon et al.
Redox biology, 36, 101586-101586 (2020-06-07)
The precise characterization and quantification of oxidative protein damage is a significant challenge due to the low abundance, large variety, and heterogeneity of modifications. Mass spectrometry (MS)-based techniques at the peptide level (proteomics) provide a detailed but limited picture due
Chris Twelves et al.
Breast cancer research and treatment, 148(3), 553-561 (2014-11-09)
Data from two phase 3 studies of eribulin were pooled in analyses initially requested by the European Medicines Agency to assess whether specific patient subgroups, previously treated with an anthracycline and a taxane, benefited from eribulin. Study 305/EMBRACE included women